5 New Stock Picks of Billionaire Ray Dalio
Moderna, Inc. (NASDAQ:MRNA) is a biotech firm that develops vaccines for people with infectious diseases.
Optimizerx Corp (OPRX)
Market is closed
Sector: Services-Business Services, Nec
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Driehaus Capital Richard Driehaus | 652,860 | $24,619 | +3% | 0.3% |
| 2. | G2 Investment Partners Management Josh Goldberg | 533,811 | $20,130 | +32% | 4.78% |
| 3. | 210,000 | $7,919 | -44% | 0.01% | |
| 4. | Renaissance Technologies Jim Simons | 90,000 | $3,394 | +935% | 0% |
| 5. | PEAK6 Capital Management Matthew Hulsizer | 89,315 | $3,368 | +115% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.49 | 15,000 | Director | 15,000 | 2020-08-07 | Filing | |
| $8.75 | 1,000 | Director | 28,022 | 2020-03-31 | Filing | |
| $9.62 | 600 | Director | 22,154 | 2019-11-13 | Filing | |
| $9.80 | 5,000 | Director | 55,092 | 2019-11-13 | Filing | |
| $9.50 | 5,000 | Officer, Director | 103,267 | 2019-11-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $44.96 | 400 | Officer, Director | 445,672 | 2022-02-18 | Filing | |
| $44.12 | 7,066 | Officer, Director | 446,072 | 2022-02-18 | Filing | |
| $43.38 | 9,200 | Officer, Director | 453,138 | 2022-02-18 | Filing | |
| $48.52 | 300 | Officer, Director | 462,338 | 2022-01-18 | Filing | |
| $47.57 | 8,226 | Officer, Director | 462,638 | 2022-01-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 8,262 | $311,560 | 0% | |
| 2. | 4,468 | $168,488 | 0% | |
| 3. | 2,683,874 | $101,208 | 0% | |
| 4. | 1,115,086 | $42,049 | 0% | |
| 5. | 828,095 | $31,227 | 0.04% |
News See All
Top 5 Stock Picks of Brandon Osten’s Venator Capital Management
In this article, we discuss the top 5 stock picks of Brandon Osten's Venator Capital Management.
OptimizeRx (OPRX) Bestowed Massive Gains, But May Be Nearing Its Peak
Wasatch Advisors, an employee-owned investment manager, published its ‘Wasatch Micro Cap Value Fund’ third-quarter 2020 Investor Letter – a copy of which can be downloaded here.
Do Hedge Funds Love OptimizeRx Corporation (OPRX)?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a...
Hedge Funds Are Dumping OptimizeRx Corporation (OPRX)
In this article you are going to find out whether hedge funds think OptimizeRx Corporation (NASDAQ:OPRX) is a good investment right now.
Hedge Funds Have Never Been More Bullish On OptimizeRx Corporation (OPRX)
Is OptimizeRx Corporation (NASDAQ:OPRX) a good bet right now? We like to analyze hedge fund sentiment before conducting days of in-depth research.
Billionaire Hedge Funds
